Quotes Matricelf Ltd OTC Markets

Stocks

Market Closed - OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

07-09	Matricelf Ltd. Receives Approval to Begin Patient Identification and Blood Collection for Planned First-In-Human Spinal Cord Injury Study	CI
06-22	Matricelf Initiates Ind Enabling Efficacy Study for Engineered Human Neural Tissue Implant in Chronic Spinal Cord Injury	CI

1 day

-40.99%

markets

Daily volume

Estimated daily volume

Record volume 1

11,025

Record volume 2

7,175

Record volume 3

Capital turnover ratio

Float rotation

Market Cap (USD)

23,937,745

Net sales ()

Number of employees

Sales / Employee ()

Sales / Employee (USD)

Free-Float

77.85 %

Free-Float capitalization (USD)

19,316,238

RSI 9 days

RSI 14 days

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MATRICELF LTD	-.--%	-.--%	-.--%	-.--%	23.94M
LONZA GROUP AG	+1.07%	-3.49%	-3.35%	+10.44%	46.86B
REVOLUTION MEDICINES, INC.	+0.25%	+1.65%	+399.22%	+634.87%	40.23B
BEONE MEDICINES AG	-0.27%	+4.45%	+11.81%	+65.64%	36.23B
IQVIA HOLDINGS INC.	+0.35%	+0.87%	+4.46%	-10.16%	34.72B
CELLTRION, INC.	+3.14%	+1.02%	+4.76%	+40.92%	27.89B
MEDPACE HOLDINGS, INC.	-0.73%	+11.84%	+34.39%	+134.36%	16.79B
ASCENDIS PHARMA A/S	+0.47%	-2.74%	-	-	16.74B
EUROFINS SCIENTIFIC SE	+0.42%	-5.52%	-3.43%	+9.03%	13.12B
ICON PUBLIC LIMITED COMPANY	-2.68%	-2.49%	-11.36%	-33.61%	12.7B
Average	-3.90%	+0.83%	+48.50%	+94.61%	24.53B
Weighted average by Cap.	+0.47%	+0.91%	+74.41%	+136.26%